Clear Street’s bioAffinity Technologies BIAFW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.9K Sell
54,927
-114
-0.2% -$36 ﹤0.01% 862
2025
Q4
$19.3K Sell
55,041
-279
-0.5% -$100 ﹤0.01% 722
2025
Q3
$18.3K Buy
55,320
+198
+0.4% +$28 ﹤0.01% 636
2025
Q2
$7.17K Hold
55,122
﹤0.01% 536
2025
Q1
$10.5K Sell
55,122
-11
-0% -$5 ﹤0.01% 365
2024
Q4
$18.5K Buy
55,133
+200
+0.4% +$169 ﹤0.01% 281
2024
Q3
$63.2K Sell
54,933
-11,083
-17% -$11.5K ﹤0.01% 183
2024
Q2
$19.8K Buy
66,016
+15,504
+31% +$7.36K ﹤0.01% 343
2024
Q1
$38.7K Buy
50,512
+25,112
+99% +$8.35K ﹤0.01% 226
2023
Q4
$2.18K Hold
25,400
﹤0.01% 539
2023
Q3
$2.32K Buy
25,400
+100
+0.4% +$30 ﹤0.01% 781
2023
Q2
$13K Buy
25,300
+100
+0.4% +$31 ﹤0.01% 656
2023
Q1
$7.56K Buy
25,200
+300
+1% +$112 ﹤0.01% 578
2022
Q4
$10K Sell
24,900
-100
-0.4% -$44 ﹤0.01% 516
2022
Q3
$9K Buy
+25,000
New +$25.9K ﹤0.01% 632

Other funds holding BIAFW

Clear Street's BIAFW Position: Q1 2026 in Review

Clear Street reduced its bioAffinity Technologies (BIAFW) stake by 0.21% in Q1 2026, selling an estimated $36 and leaving 54,927 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

Clear Street first reported a position in BIAFW in Q3 2022 and has held it in 15 quarters since. The position peaked at $63.2K in Q3 2024. 4 funds tracked by Wall St. Rank hold BIAFW as of Q1 2026.

  • Clear Street held 54,927 shares of bioAffinity Technologies worth $24.9K as of Q1 2026.
  • Clear Street sold 114 bioAffinity Technologies shares in Q1 2026, an estimated $36.
  • bioAffinity Technologies made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #862 holding.
  • Clear Street first reported a position in bioAffinity Technologies in Q3 2022 and has held it in 15 quarters since.
  • Clear Street's bioAffinity Technologies position peaked at $63.2K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.